Abstract：The premembrane and envelope proteins (prM-E), which contains the mainly protective antigen related with virulence and tropism, are the primary structural protein of flavivirus. However, prM-E in ZIKV is rarely understood. We have analyzed the structure and biological effects of prM-E in ZIKV by bionformatics methods. The prM-E proteins virus-like particles of dengue virus was introduced in the present. Then, the prM-E proteins virus-like particles of ZIKV was prospected.
卢昌, 李娜, 薛璞, 李楠, 陈平. 寨卡病毒包膜prM-E蛋白的结构和功能分析[J]. 中国人兽共患病学报, 2017, 33(1): 81-84.
LU Chang, LI Na, XUE Pu, LI Nan, CHEN Ping. Function and structure analysis of premembrane and envelope proteins of Zika virus. Chinese Journal of Zoonoses, 2017, 33(1): 81-84.
[1] Faqbami AH. Zika virus infection in Nigeria: virological and seroepidemiological investigations in Oyo State[J]. J Hyg (Lond), 1979, 83(2): 213-219. [2] Hayes EB. Zika virus outside Africa[J]. Emerg Infect Dis, 2009, 15(9): 1347-1350. [3] Messina JP, Kraemer MU, Brady OJ, et al. Mapping global environmental suitability for Zika virus[J]. Elife, 2016, 19(5): e15272. [4] Cunha MS, Esposito DL, Rocco IM, et al. First complete genome sequence of Zika virus ( Flaviviridae , Flavivirus ) from an autochthonous transmission in Brazil[J]. Genome Announc, 2016, 4(2): e00032-16. [5] Hamel R, Dejarnac O, Wichit S, et al. Biology of Zika virus infection in human skin cells[J]. J Virol, 2015, 89(17): 8880-8896. [6] Lobiqs M, Lee E. Inefficient signalase cleacage promotes efficient nucleocapsid incorporation into budding flavivirus membranes[J]. J Virol, 2004, 78(1): 178-186. [7] Paul D, Bartenschlager R. Flaviviridae replication organelles: Oh, what a tangled web Weave[J]. Annu Rev Virol, 2015, 2(1): 289-310. [8] Purdy DE, Chang GJ. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein[J]. Virology, 2005, 333(2): 239-250. [9] de Wispelaere M, Yang PL. Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly[J]. J Virol, 2012, 86(13): 7072-7083. [10] Kostyuchenko AV, Lim EX, Zhang S, et al. Structure of the thermally stable Zika virus[J]. Nature, 2016, 19. [11] Haddow AD, Schuh AJ, Yasuda CY, et al. Genetia charaterization of Zika virus strains:geographic expansion of the Asian lineage[J]. PLoS Negl Trop Dis, 2016, 6(2): e1477. [12] Faye O, Ferire CC, Iamarino A, et al. Molecular evolution of Zika virus during its emergence in the 20(th) century[J]. PLoS Negl Trop Dis, 2014, 8(1): e2636. [13] Zhang W, Chipman PR, Corver J, et al. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus[J]. Nat Struct Biol, 2003, 10(11): 907-912. [14] Doll TA, Dey R, Burkhard P. Design and optimization of peptide nanoparticles[J]. J Nanobiotechnol, 2015, 13: 73. [15] Lopez-Sagaseta J, Malito E, Rappuoli R, et al. Self-assembling protein anoparticles in the design of vaccines[J]. Comput Struct Biotechnol, 2015, 14: 58-68. [16] Medina GN, Montiel N, Diaz-San Sequndo F, et al. Evaluation of a fiber-modified adenovirus vector vaccine against foot-and-mouth disease in cattle[J]. Clin Vaccine Immunol, 2015, 23(2): 125-136. [17] Xi X, Mo X, Xiao Y, et al. Production of Escherichia coli -based virus-like particle vaccine against porcine cirovirus type 2 challenge in piglets: structure characterization and protective efficacy validation[J]. J Biotechnol, 2016, 10(223): 8-12. [18] Benen TD, Tonks P, Kliche A, et al. Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein[J]. J Biomec Sci, 2014, 27(21): 79. [19] Bryan JT, Buckland B, Hammond J, et al. Prevention of cervical cancer: journey to developthe first human papillomvirus virus-like particle vaccine and the next generation vaccine[J]. Curr Opin Chem Biol, 2016, 32: 34-47. [20] Liu Y, Zhou J, Yu Z, et al. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties[J]. BMC Microbiol, 2014, 14: 233. [21] Chang GJ, Hunt AR, Holmes DA, et al. Enhancing biosynthesis and secretion of premembrane and encelop proteins by the chimeric plasmid of dengue cirus type 2 and Japanses encephalitis virus[J]. Virology, 2003, 306(1): 170-180. [22] Hsieh SC, Liu IJ, King CC, et al. A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles[J]. Virology, 2008, 374(2): 338-350. [23] Shang W, Liu J, Yang J, et al. Dengue virus-like particles: construction and application[J]. Appl Microbiol Biotechnol, 212, 94(1): 39-46. [24] Scallan CD, Lindbloom JD, Tucker SN. Oral modeling of an adenovirus-based quadricalent influenza vaccine in ferrets and mice[J]. Infect Dis Ther, 2016, 12. [25] Sedegah M, Hollingdale MR, Faroog F, et al. Controlled human malaria infection (CHMI) differentially affects cell-mediared and antibody responses to CSP and AMA1 induced by adenovitus vaccines with and without DNA-priming[J]. Hum Vaccin Immunother, 2015, 11(11): 2705-2715.
2017, Vol. 33 
